MedPath

Can Steerable Capsule Endoscopy Enhance Gastric Emptying?

Not Applicable
Completed
Conditions
Patients Attending Hospital for Small Bowel Endoscopy
Registration Number
NCT02282852
Lead Sponsor
Sheffield Teaching Hospitals NHS Foundation Trust
Brief Summary

Small bowel wireless capsule endoscopy is the investigation modality of choice for suspected diseases of the small bowel. The procedure is safe and noninvasive, the main risk being capsule retention occurring in approximately 2% of procedures. Other problems such as incomplete examinations occur in 10-20% of procedures. Reasons include delayed gastric emptying, slow small bowel transit, faulty equipment and poor bowel preparation.

Some protocols identify the capsule position 30 minutes after ingestion using a 'realtime' viewer. If the capsule remains in the stomach, mobilisation is encouraged followed by an intramuscular prokinetic injection if this fails. This approach has disadvantages since an intramuscular injection is uncomfortable for patients. Additionally metoclopramide, commonly used for this purpose, has a risk of acute dystonic reactions particularly in young patients.

Recently a handheld magnet (Intromedic Ltd.) has been developed to enable control of the capsule in the upper GI tract. We propose that this could be used, alongside positional changes, to expedite capsule transit through the stomach thus improving completion rates and avoiding the risks of unnecessary medication. We wish to undertake a randomised controlled study comparing a standard protocol for small bowel capsule endoscopy against a hand held magnet and positional change protocol to enhance gastric emptying of the wireless capsule.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
24
Inclusion Criteria
  • Patients aged 20 years or over
  • Patients attending hospital for small bowel endoscopy examination
Exclusion Criteria
  • Patients under the age of 20 years
  • Patients with a permanent pacemaker, or implantable cardioverter-defibrillator
  • Patients with any electronic/magnetic/mechanically controlled devices
  • Patients that are pregnant
  • Patients who are unable to understand or speak English

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Primary Outcome Measures
NameTimeMethod
Duration of time taken for camera capsule to enter duodenum.Baseline
Completion rate of small bowel endoscopy examinationBaseline
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Royal Hallamshire Hospital

🇬🇧

Sheffield, South Yorkshire, United Kingdom

Royal Hallamshire Hospital
🇬🇧Sheffield, South Yorkshire, United Kingdom

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.